A Phase I Trial to Evaluate the Multiple-Dose Safety and Antitumor Activity of Ursolic Acid Liposomes in Subjects with Advanced Solid Tumors

Table 3

Ursolic acid liposome pharmacokinetic parameters for the 1st and 14th days (mean ± standard deviation, SD; ).

Parameter	Unit	Day 1	Day 14
		Mean ± SD	Mean ± SD
	h
	L/m^2
CL	L/(h·m^2)
	ng·h/mL
	ng·h/mL
	h
	h
	h
	ng/mL